Aspiration Pneumonia among Older Adults

Size: px
Start display at page:

Download "Aspiration Pneumonia among Older Adults"

Transcription

1 Lung Disease among Older Adults R.A. Harrison, MD, FRCPC, Department of Internal Medicine and Division of Infectious Diseases, University of Alberta, Edmonton, AB. T.J. Marrie, MD, FRCPC, Department of Internal Medicine and Division of Infectious Diseases, University of Alberta, Edmonton, AB. Among older adults, aspiration pneumonia is associated with higher rates of morbidity and mortality than community-acquired pneumonia. Individuals admitted to acute care from continuing care facilities are at increased risk for aspiration pneumonia. Risk factor assessment forms a cornerstone in diagnosing aspiration pneumonia syndromes. Monitoring for timely clinical response to therapy and for potential complications is an important step in the care of patients with aspiration pneumonia. Further high-quality research is needed to better delineate the effects of risk factor modification on the incidence of aspiration pneumonia. Aiming to prevent aspiration pneumonia poses health care providers with an opportunity for ongoing development, study, and implementation of preventive strategies for older adults. Key words: aspiration, pneumonia, older adults, geriatric, risk factor Introduction Aspiration occurs, and is resolved, on a daily basis in healthy people of all ages, 1,2 but, occasionally, aspiration results in pulmonary syndromes. A key distinction is defined by Marik, 3 who defines aspiration pneumonitis as acute lung injury due to gastric contents, and aspiration pneumonia as a radiographic infiltrate and bacterial infection in an individual at increased risk of aspiration. Others would divide the pulmonary syndromes into three distinct categories: chemical pneumonitis (Mendelson s syndrome), foreign body obstructive pneumonia, and aspirated bacteria causing pulmonary infection (aspiration pneumonia). 4 Aspiration pneumonia is associated with a statistically significant increase in the rate of intensive care admissions, mortality, and hospital costs 5 compared with community-acquired pneumonia (CAP) alone, particularly among older adults. 6 We aim to summarize the diagnosis, risk factors, complications, prevention, and treatment of aspiration pneumonia among older adults. A clinical case is used to highlight some of the key issues. Case Report A 70-year-old man with a longstanding history of alcohol use was assaulted while intoxicated and was reportedly left on the ground for a 3-day period. He was brought to a community emergency department and, although rousable, was found to have a temperature of 38.9 C. He was coughing, and his oxygen saturations were 85% while breathing room air. A chest radiograph confirmed lower lobe opacities (Figure 1). How would you manage this patient? What is his diagnosis, and what would you prescribe for his fever? Ten days later, despite antibiotic therapy, he still had fever measuring up to 39.0 C. What would be your approach at this stage? Diagnosis The diagnosis of aspiration pneumonia can be challenging. Aspiration may be described as macro (typically large volume and witnessed) or micro (often unknown to the patient but described by scintigraphic studies). 7 Just as aspiration may vary in inoculum size, it may also vary in clinical presentation and course. For this reason, precise definitions are difficult and are variable in clinical practice and in research studies. Aspiration of naso- or oropharyngeal contents may result in aspiration of typical respiratory pathogens such as Haemophilus influenzae, Streptococcus pneumoniae, 3 gram-negative bacilli and Staphylococcus aureus, 2 but aspiration of anaerobic oral flora is also possible. Studies conducted in the 1970s by Bartlett et al., succeeded in isolating anaerobes from transtracheal aspiration Commonly isolated anaerobes included Peptostreptococcus spp., Fusobacterium nucleatum, Prevotella spp., and Bacteroides spp. A later study of institutionalized individuals with risk factors for aspiration who were admitted to intensive care with pneumonia also demonstrated anaerobic bacteria isolated from respiratory specimens in at least 16% of individuals. 12,13 Unlike the case with typical pyogenic pathogens, a higher inoculum is likely required for clinical disease to result from anaerobic bacteria. The source of the inoculum is typically the oropharynx; thus, assessment of oral hygiene is important for the diagnosis and recognition of aspiration pneumonia syndromes. Gram stains of bronchial brush specimens, or even sputum specimens, are occasionally helpful but are limited by variable sensitivity and specificity. 14 Characteristic morphologies of anaerobic bacteria, such as that of Fusobacterium spp. or Actinomyces spp., may be recognized on Gramstained specimens (as in the polymicrobial specimen shown in Figure 2), but Gram stain interpretation requires expertise in microscopy, and not all anaerobic bacteria have such distinctive morphology. Complicating definitive etiological diagnosis, anaerobic bacteria are not routinely cultured from respiratory specimens. Anaerobic bacteria may not survive transport in usual aerobic transport systems, they may be particularly 111

2 Figure 1: Chest Radiograph of Patient Admitted with Aspiration Pneumonia This radiograph was taken of the patient described in the case report. Note the patchy opacities at the lung bases, suggestive of acute inflammatory changes (more prominent on the right side). Source: Dr. R. Harrison and Dr. T. Marrie. difficult to isolate after even a single dose of antibiotic, and they are not easily cultivated from clinical specimens, even in experienced laboratories, where specialized equipment such as a gas chromatograph would often be required for speciation. Microbiological diagnosis from respiratory specimens, at least in the current era of bacterial culture, is not prompt or definitive, so treatment is typically prescribed based on empirical principles. For this reason, identification of aspiration risk factors forms a cornerstone in the diagnosis of aspiration pneumonia. Risk Factor Assessment In the clinical case presented, the patient s chronic alcohol use, acute intoxication, and decreased level of consciousness all put him at risk for aspiration pneumonia. 2,5 On further examination, he was found to have severe periodontal disease and putrid sputum, which put him at risk for anaerobic infection. His case represents a typical profile of patients with CAP at high risk for aspiration and anaerobic infection. Periodontal disease and oral hygiene have been the focus for research in pneumonia syndromes. Researchers have examined dental plaque of dependent older adults. 6,15 Sumi et al. 6 demonstrated that dental and denture plaque may serve as reservoirs for respiratory pathogens. They found respiratory pathogens in 64.5% of subjects dental plaque, and while this was 1.5 times higher than that found on denture plaque, both dental and denture plaque were demonstrated to be potential reservoirs for respiratory pathogens. Similarly, Abe et al. 15 demonstrated that tongue coating was associated with viable salivary bacterial cells among edentulate individuals, and they have developed a tongue-coating index to be tested as a tool for pneumonia risk assessment among edentulate individuals. There is clear evidence that the oropharynx, be it in persons with or without teeth or dentures, is a potential reservoir for pneumonia-causing pathogens. Older adults living in long-term care (LTC) facilities represent a unique subpopulation at increased risk for aspiration pneumonia. In a recent cohort study, 5 aspiration was diagnosed among roughly 10% of individuals admitted to hospital with CAP, which is consistent with previous studies, but 30% of individuals from LTC facilities admitted to hospital with CAP were diagnosed with aspiration pneumonia. Additional risk factors for pneumonia studied in cohorts of individuals in LTC facilities include poor swallowing capabilities, 16,17 lack of dental care (defined as the lack of a dental visit within the past year), 16 and lack of influenza vaccination (increasing the risk of lower respiratory infection or pneumonia). 17 Cerebrovascular disease, neuromuscular disorders, and disorders of the basal ganglia likely account for many of the swallowing difficulties of persons in LTC facilities and pose a risk for aspiration. 5 Clinical Considerations Including Potential Complications The case presented describes an individual who remained febrile 10 days after appropriate antimicrobial therapy was initiated. When bacterial pneumonia is suspected, an important next step in continued care is monitoring the time to clinical response after appropriate antibiotic therapy is initiated. Studies demonstrate that patients may be expected to defervesce in approximately 2 4 days following hospital admission with CAP. 18 In a multicentre observational cohort study, the median time to resolution of fever following admission for CAP (temperature <37.2 C) was 3 days. The median time to stability was 2 days for heart rate (<100 beats/minute) and systolic blood pressure (>90 mm Hg) and 3 days for respiratory rate (<24 breaths/minute) and oxygen saturation (>90%). The median time to overall clinical stability was 3 days for the most lenient definition of stability and 7 days for the most conservative definition. 18 Careful and repeated reassessments of antibiotic therapy are important, but so too is investigation for complications of pneumonia and other potentially coincident etiologies for fever. Knowledge of expected times to clinical response should guide further investigation and reassessment. Empyema and lung abscesses are serious potential complications of aspiration pneumonia. Anaerobes are frequently isolated from empyema. 19 Diagnosing these potential sequelae requires repeat Figure 2: Gram-Stained Polymicrobial Sputum Specimen This specimen includes morphologies suggestive of Fusobacterium and Actinomyces spp., along with two morphotypes of gram-positive cocci. Source: Photo courtesy of Dr. Jana Nigrin of Dynacare Kasper Medical Laboratories, Edmonton, AB. 112 GERIATRICS & AGING March 2008 Volume 11, Number 2

3 Figure 3: Computed Tomographic Chest Scan of a Patient with This computed tomographic scan was taken of the patient described in the case report. This scan confirmed the consolidation. Although the patient did have a small lung effusion, he did not have lung abscess and ultimately did not have empyema as a source for his fever. The absence of these potential complications prompted the concomitant search for an alternative etiology for his fever when he failed to reach clinical stability in the expected time. chest radiography and, if necessary, computed tomography. This is a key clinical consideration because antibiotic therapy alone is unlikely to be successful. Drainage or surgical débridement are often necessary adjuncts for cure. In the case presented, the initial antibiotic coverage was appropriate, and there was no evidence of lung abscess or empyema on computed tomography (Figure 3). The search for a concomitant etiology for his fever led to an obvious source: his poor dentition (see Figure 4). A dental panoramic radiograph confirmed multiple dental abscesses (Figure 5). After more than a week of fever on Figure 4: Mouth and Dentition of a Patient Admitted with Aspiration Pneumonia This photo was taken of the patient described in the case report. Note the very poor oral hygiene. Source: Courtesy Dr. R. Harrison and Dr. T. Marrie. appropriate antibiotic therapy, his fever resolved within 48 hours of dental extraction. The diagnosis for this case is perhaps best defined as severe periodontal disease complicated by multiple dental abscesses and aspiration pneumonia. Prevention Just as risk factors form a cornerstone for diagnosis, prevention should form the foundation for any discussion on treatment. Despite established risk factors, a systematic review of the literature ( ) found insufficient data to determine the effectiveness of aspiration pneumonia preventive strategies. 20 This systematic review was restricted to randomized controlled clinical trials (RCTs) and included an assessment of positioning strategies, modified diets, oral hygiene, feeding tube placement, and methods of food delivery. The effectiveness of oral hygiene programs appeared promising in one RCT by Yoneyama, et al. 21 but was of borderline statistical significance. While pharmacological strategies have also been proposed (e.g., amantadine and cilostazol), the potential for harm with these drugs could limit their acceptability. A systematic review of controlled prospective studies of pharmacological preventions of aspiration ( ) concluded that there are insufficient data to support an evidencedbased approach to aspiration pneumonia prevention with pharmacological agents at this time. 22 Loeb, et al. 20 called for more large, high-quality RCTs on the effectiveness of these preventive interventions because aspiration pneumonia is common and associated with significant morbidity and mortality among older adults. Robust evidence could help guide the standard implementation of preventive interventions in care facilities and education programs for caregivers. Evidence-based preventive measures should guide future technology and preventive strategy implementation. In the interim, the identification of potentially modifiable risks such as periodontal disease, poor oral hygiene, excessive alcohol use, and witnessed positional aspiration should prompt intervention aimed at eliminating the risks. Treatment Once a patient is diagnosed with CAP, treatment regimens may be considered and tailored to individual risk profiles. If uncomplicated, the treatment of CAP due to an aspirated bacterial inoculum relies primarily on antibiotic therapy. In the case presented, we learned that the patient had putrid sputum and poor oral hygiene. A further historytaking revealed that his symptoms were subacute and included nonspecific symptoms such as fatigue and anorexia for days before he developed cough and fever. These findings are in keeping with a potential anaerobic pulmonary infection. It is perhaps important to recognize that not every patient fits this classic description for anaerobic infection, and that anaerobic bacterial coverage may not always be necessary. Recommendations for the management of aspiration pneumonia differ, and a frequent debate is whether anaerobic coverage is indicated. The Infectious Disease Society of America/American Thoracic Society 2007 guidelines state that the need for specific anaerobic coverage for CAP is generally overestimated and that antibiotic trials have not demonstrated a need to specifically treat these organisms Figure 5: Dental Panoramic Radiograph of a Patient with This radiograph was taken of the patient described in the case report. It confirms dental abscesses as complications of his severe periodontal disease. The patient defervesced within 48 hours after his abscessed teeth were extracted, and he remained afebrile. Source: Dr. R. Harrison and Dr. T. Marrie

4 in the majority of CAP cases. 23 They further state that anaerobic coverage is clearly indicated only in the classic aspiration pleuropulmonary syndrome in patients with a history of loss of consciousness as a result of alcohol/drug overdose or after seizures in patients with concomitant gingival disease or esophageal motility disorders. For such cases, they recommend therapy with amoxicillin and clavulanic acid or with clindamycin. For all other cases, they recommend therapy with a respiratory fluoroquinolone or a beta-lactam and macrolide combination. In the clinical case presented, the patient was prescribed moxifloxacin. As a fourth-generation fluoroquinolone with demonstrated anaerobic activity in vitro, 2 this is a suitable option. Moxifloxacin should provide broad gram-positive (including Streptococcus pneumoniae and methicillin-susceptible Staphylococcus aureus), gram-negative (including Klebsiella spp., Haemophilus influenzae, and Moraxella spp.), anaerobic (including Peptostreptococcus spp., Bacteroides spp., and Fusobacterium spp.), and atypical organism coverage (for Mycoplasma spp., Chlamydia pneumoniae, or Legionella spp.). This choice is supported by recommendations from the Canadian Infectious Diseases Society and the Canadian Thoracic Society in the Canadian Guidelines for the Initial Management of Community- Acquired Pneumonia, published in Other recommended options included amoxicillin and clavulanic acid plus a macrolide or a third-generation respiratory quinolone (e.g., levofloxacin) with metronidazole or clindamycin. 24 An additional important consideration with all cases of CAP is whether there is a risk for the typically nosocomial-acquired and aggressive pathogens such as Pseudomonas aeruginosa, drugresistant Streptococcus pneumoniae, and methicillin-resistant Staphylococcus aureus. These are particularly important considerations for older adults who may visit hospitals repeatedly as in- or outpatients, including those who live in LTC facilities. When studied, the population with frequent health care visits was reported to Key Points Risk factor assessment is key to diagnosis and, ideally, prevention of aspiration pneumonia. Risk factors for aspiration pneumonia, such as poor oral hygiene, impaired swallowing capability, neurological disease, or decreased level of consciousness, are prevalent among older adults, and particularly those living in long-term care facilities. Older adults with teeth or dentures, and even edentulous older adults, may harbour respiratory pathogens in their oropharynx that are easily aspirated. Bacterial pathogens may include anaerobic bacteria in aspiration pneumonia syndromes, and antibiotic therapy should be based on individual patient risk profiles. The expected time to clinical stability with pneumonia syndromes is 3 days from the time appropriate antibiotic therapy is initiated. If response is delayed, physicians should consider inappropriate antibiotic coverage, screen for potential complications of pneumonia, and consider other diagnoses. be more prone to aspiration and less likely to receive appropriate empirical antibiotic therapy (appropriate was defined as amoxicillin and clavulanic acid for suspected aspiration). 25 These individuals merit careful and targeted assessment. While the focus of this review has been aspiration pneumonia, rather than chemical pneumonitis, it should be noted that the management of chemical pneumonitis may also be challenging. In 1946, Mendelson described a classic syndrome of acute respiratory distress associated with radiographic infiltrates after ether anesthesia in a series of 61 obstetrical patients who aspirated gastric contents. 2 Although all the individuals recovered, subsequent study suggests that some people may develop acute respiratory distress syndrome before improving, and some may go on to develop secondary bacterial pneumonia. 2 Careful observation for developing signs of infection or complication seems a reasonable approach. Conclusion In summary, while definitions for aspiration pneumonia are variable, clearly identifiable risk factors for aspiration combined with chest radiographs showing infiltrate and clinical symptoms suggestive of pneumonia should prompt the diagnosis of aspiration pneumonia and treatment to prevent repeated pneumonia among older adults. In select cases of aspiration pneumonia, anaerobic bacteria may be the pathogens involved. Treatment regimens should reflect this possibility and should be tailored to each individual patient s clinical syndrome and presentation. The diagnosis of aspiration should not detract from the basic management of CAP among older adults. Patients should be monitored for appropriate clinical response to therapy, and if response is delayed, potential complications such as empyema and lung abscess should be considered. Aspiration pneumonia is a common and significant problem among older individuals; it poses health care providers with the opportunity for the ongoing development, study, and implementation of preventive strategies. No competing financial interests declared. References 1. Sa-Borges M, Rello J. Aspiration pneumonia. In: Marrie TJ, ed. Community- Acquired Pneumonia. New York: Springer; 2001: Bartlett JG. Aspiration pneumonia in adults. In: Rose BD, ed. UpToDate. Waltham, MA: UpToDate; Marik PE. Aspiration pneumonitis and aspiration pneumonia. N Engl J Med 2001;344: Donowitz GR, Mandell GL. Acute pneumonia. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practices of Infectious 114 GERIATRICS & AGING March 2008 Volume 11, Number 2

5 Diseases. Philadelphia, PA: Elsevier Churchill Livingstone; 2005: Reza Shariaztzadeh M, Huang J, Marrie TJ. Differences in the features of aspiration pneumonia according to site of acquisition: community or continuing care facility. J Am Geriatr Soc 2006;54: Sumi Y, Miura H, Michiwaki Y, et al. Colonization of dental plaque by respiratory pathogens in dependent elderly. Arch Gerontol Geriatr 2007;44: Berson W, Adriani J. Silent regurgitation and aspiration during anesthesia. Anesthesiology 1954;15: Bartlett JG, Gorbach SL. The triple threat of aspiration pneumonia. Chest 1975;68: Bartlett JG. Anaerobic bacterial infections of the lung and pleural space. Clin Infect Dis 1993;16 Suppl 4:S Bartlett JG. Anaerobic bacterial pneumonitis. Am Rev Respir Dis 1979;119: Bartlett JG. Diagnostic accuracy of transtracheal aspiration bacteriologic studies. Am Rev Respir Dis 1977;115: Finegold SM. Aspiration pneumonia. Rev Infect Dis 1991;13 Suppl 9:S El-Solh AA, Pietrantoni C, Bhat A, et al. Microbiology of severe aspiration pneumonia in institutionalized elderly. Am J Respir Crit Care Med 2003;167: Reed WW, Byrd GS, Gates RH Jr, et al. Sputum Gram s stain in community acquired pneumococcal pneumonia: a meta-analysis. West J Med 1996;165: Abe S, Ishihara K, Adachi M, et al. Tongue-coating as risk indicator for aspiration pneumonia in edentate elderly. Arch Gerontol Geriatr 2007;October 1:[Epub ahead of print]. 16. Quagliarello V, Ginter S, Han L, et al. Modifiable risk factors for nursing home-acquired pneumonia. Clin Infect Dis 2005;40: Loeb M, McGreer A, McArthur M, et al. Risk factors for pneumonia and other lower respiratory tract infections in elderly residents of long-term care facilities. Arch Intern Med 1999;159: Halm EA, Fine MJ, Marrie TJ, et al. Time to clinical stability in patients hospitalized with community-acquired pneumonia. JAMA 1998;279: Ahmed R, Marrie TJ, Huang JQ. Thoracic empyema in patients with community-acquired pneumonia. Am J Med 2006;119: Loeb M, Becker M, Eady A, et al. Interventions to prevent aspiration pneumonia in older adults: a systematic review. J Am Geriatr Soc 2003;51: Yoneyama T, Yoshida M, Matsui T, et al. Oral care and pneumonia. Lancet 1999;354: El Solh AA, Saliba R. Pharmacologic prevention of aspiration pneumonia: a systematic review. Am J Geriatr Pharmacother 2007;5: Mandell L, Wunderink R, Anzueto A, et al. Infectious Disease Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007;44 Suppl 2:S Mandell LA, Marrie TJ, Grossman RF, et al. Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society. Clin Infect Dis 2000;31: Carratala J, Mykkietiuk A, Fernandez-Sabe N, et al. Health care-associated pneumonia requiring hospital admission. Arch Intern Med 2007;167:

GUIDELINES FOR THE MANAGEMENT OF COMMUNITY-ACQUIRED PNEUMONIA IN ADULTS

GUIDELINES FOR THE MANAGEMENT OF COMMUNITY-ACQUIRED PNEUMONIA IN ADULTS Version 3.1 GUIDELINES FOR THE MANAGEMENT OF COMMUNITY-ACQUIRED PNEUMONIA IN ADULTS Date ratified June 2008 Updated March 2009 Review date June 2010 Ratified by Authors Consultation Evidence base Changes

More information

Measure Information Form

Measure Information Form Release Notes: Measure Information Form Version 3.0b **NQF-ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE** Measure Set: Pneumonia (PN) Performance Measure Identifier: Measure Information Form

More information

Community Acquired Pneumonia: An Update on Guidelines

Community Acquired Pneumonia: An Update on Guidelines Community Acquired Pneumonia: An Update on Guidelines Claudia Summa, BScPhm Pharmacy Resident September 12, 2006 Objectives To give a brief description of the pathophysiology of community acquired pneumonia

More information

Control emergence of drug-resistant. Reduce costs

Control emergence of drug-resistant. Reduce costs ...PRESENTATIONS... Guidelines for the Management of Community-Acquired Pneumonia Richard E. Chaisson, MD Presentation Summary Guidelines for the treatment of community-acquired pneumonia (CAP) have been

More information

NQF-ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE. Measure Information Form

NQF-ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE. Measure Information Form Last Updated: Version 3.2a NQF-ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE Measure Set: Pneumonia (PN) Performance Measure Identifier: Measure Information Form Organization Set Measure ID#

More information

NQF-ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE. Measure Information Form Collected For: CMS Voluntary Only

NQF-ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE. Measure Information Form Collected For: CMS Voluntary Only Last Updated: Version 4.4a NQF-ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE Measure Set: Pneumonia (PN) Performance Measure Identifier: Measure Information Form Collected For: CMS Voluntary

More information

Int.J.Curr.Microbiol.App.Sci (2017) 6(3):

Int.J.Curr.Microbiol.App.Sci (2017) 6(3): International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 6 Number 3 (2017) pp. 891-895 Journal homepage: http://www.ijcmas.com Original Research Article https://doi.org/10.20546/ijcmas.2017.603.104

More information

Guidelines for the Initiation of Empirical Antibiotic therapy in Respiratory Disease (Adults)

Guidelines for the Initiation of Empirical Antibiotic therapy in Respiratory Disease (Adults) Guidelines for the Initiation of Empirical Antibiotic therapy in Respiratory Disease (Adults) Community Acquired Community Acquired 1) Is it pneumonia? ie new symptoms and signs of a lower respiratory

More information

Antibiotics in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Antibiotics in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease Antibiotics in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease Sung Kyu Kim, M.D.Young Sam Kim, M.D. Department of Internal Medicine Yonsei University College of Medicine,

More information

What is pneumonia? Infection of the lung parenchyma Causative agents include bacteria, viruses, fungi, protozoa.

What is pneumonia? Infection of the lung parenchyma Causative agents include bacteria, viruses, fungi, protozoa. Pneumonia What is pneumonia? Infection of the lung parenchyma Causative agents include bacteria, viruses, fungi, protozoa www.netmedicine.com/xray/xr.htm Definition acute infectious disease, etiology usually

More information

Guidelines for the Initiation of Empirical Antibiotic therapy in Respiratory Disease (Adults)

Guidelines for the Initiation of Empirical Antibiotic therapy in Respiratory Disease (Adults) Guidelines for the Initiation of Empirical Antibiotic therapy in Respiratory Disease (Adults) Community Acquired Pneumonia Community Acquired Pneumonia 1) Is it pneumonia? ie new symptoms and signs of

More information

Treatment Duration for Uncomplicated Community-Acquired Pneumonia: The Evidence in Support of 5 Days

Treatment Duration for Uncomplicated Community-Acquired Pneumonia: The Evidence in Support of 5 Days Treatment Duration for Uncomplicated Community-Acquired Pneumonia: The Evidence in Support of 5 Days Executive Summary National consensus guidelines created jointly by the Infectious Diseases Society of

More information

M5 MEQs 2016 Session 3: SOB 18/11/16

M5 MEQs 2016 Session 3: SOB 18/11/16 M5 MEQs 2016 Session 3: SOB 18/11/16 http://tinyurl.com/hn7qzt3 Question 1 Ms Tan is a 52 year old female with no past medical history. She comes to the emergency department presenting with a fever for

More information

CLINICAL PROTOCOL FOR COMMUNITY ACQUIRED PNEUMONIA. SCOPE: Western Australia. CORB score equal or above 1. All criteria must be met:

CLINICAL PROTOCOL FOR COMMUNITY ACQUIRED PNEUMONIA. SCOPE: Western Australia. CORB score equal or above 1. All criteria must be met: CLINICAL PROTOCOL F COMMUNITY ACQUIRED PNEUMONIA SCOPE: Western Australia All criteria must be met: Inclusion Criteria Exclusion Criteria CB score equal or above 1. Mild/moderate pneumonia confirmed by

More information

Safety of an Out-Patient Intravenous Antibiotics Programme

Safety of an Out-Patient Intravenous Antibiotics Programme Safety of an Out-Patient Intravenous Antibiotics Programme Chan VL, Tang ESK, Leung WS, Wong L, Cheung PS, Chu CM Department of Medicine & Geriatrics United Christian Hospital Outpatient Parental Antimicrobial

More information

IDSA GUIDELINES COMMUNITY ACQUIRED PNEUMONIA

IDSA GUIDELINES COMMUNITY ACQUIRED PNEUMONIA page 1 / 5 page 2 / 5 idsa guidelines community acquired pdf IDSA/ATS Guidelines for CAP in Adults CID 2007:44 (Suppl 2) S29 such as blood and sputum cultures. Conversely, these cultures may have a major

More information

Suitability of Antibiotic Treatment for CAP (CAPTIME) The duration of antibiotic treatment in community acquired pneumonia (CAP)

Suitability of Antibiotic Treatment for CAP (CAPTIME) The duration of antibiotic treatment in community acquired pneumonia (CAP) STUDY PROTOCOL Suitability of Antibiotic Treatment for CAP (CAPTIME) Purpose The duration of antibiotic treatment in community acquired pneumonia (CAP) lasts about 9 10 days, and is determined empirically.

More information

ESISTONO LE HCAP? Francesco Blasi. Sezione Medicina Respiratoria Dipartimento Toraco Polmonare e Cardiocircolatorio Università degli Studi di Milano

ESISTONO LE HCAP? Francesco Blasi. Sezione Medicina Respiratoria Dipartimento Toraco Polmonare e Cardiocircolatorio Università degli Studi di Milano ESISTONO LE HCAP? Francesco Blasi Sezione Medicina Respiratoria Dipartimento Toraco Polmonare e Cardiocircolatorio Università degli Studi di Milano Community-acquired pneumonia (CAP): Management issues

More information

Pneumonia considerations Galia Rahav Infectious diseases unit Sheba medical center

Pneumonia considerations Galia Rahav Infectious diseases unit Sheba medical center Pneumonia considerations 2017 Galia Rahav Infectious diseases unit Sheba medical center Sir William Osler (1849 1919) "Father of modern medicine Pneumonia: The old man's friend The captain of the men of

More information

Basic principles of antibiotic use

Basic principles of antibiotic use Basic principles of antibiotic use Michal Holub Department of Infectious Diseases First Faculty of Medicine Charles University and Military University Hospital, Prague 1. Is antibiotical treatment indicated

More information

Pharmacokinetics. Absorption of doxycycline is not significantly affected by milk or food, but coadministration of antacids or mineral supplements

Pharmacokinetics. Absorption of doxycycline is not significantly affected by milk or food, but coadministration of antacids or mineral supplements Pharmacokinetics. Absorption of doxycycline is not significantly affected by milk or food, but coadministration of antacids or mineral supplements should be avoided. PDR Drug Summaries are concise point-of-care

More information

Cipro for gram positive cocci in urine

Cipro for gram positive cocci in urine Buscar... Cipro for gram positive cocci in urine 20-6-2017 Pneumonia can be generally defined as an infection of the lung parenchyma, in which consolidation of the affected part and a filling of the alveolar

More information

11/10/2016. Skin and Soft Tissue Infections. Disclosures. Educational Need/Practice Gap. Objectives. Case #1

11/10/2016. Skin and Soft Tissue Infections. Disclosures. Educational Need/Practice Gap. Objectives. Case #1 Disclosures Selecting Antimicrobials for Common Infections in Children FMR-Contemporary Pediatrics 11/2016 Sean McTigue, MD Assistant Professor of Pediatrics, Pediatric Infectious Diseases Medical Director

More information

Inappropriate Use of Antibiotics and Clostridium difficile Infection. Jocelyn Srigley, MD, FRCPC November 1, 2012

Inappropriate Use of Antibiotics and Clostridium difficile Infection. Jocelyn Srigley, MD, FRCPC November 1, 2012 Inappropriate Use of Antibiotics and Clostridium difficile Infection Jocelyn Srigley, MD, FRCPC November 1, 2012 Financial Disclosures } No conflicts of interest } The study was supported by a Hamilton

More information

Compliance with antibiotic treatment guidelines in managed care patients with communityacquired pneumonia in ambulatory settings

Compliance with antibiotic treatment guidelines in managed care patients with communityacquired pneumonia in ambulatory settings Compliance with antibiotic treatment guidelines in managed care patients with communityacquired pneumonia in ambulatory settings Jasmanda H. Wu, Ph.D., 1 David H. Howard, Ph.D., 2 John E. McGowan, Jr.,

More information

Combination vs Monotherapy for Gram Negative Septic Shock

Combination vs Monotherapy for Gram Negative Septic Shock Combination vs Monotherapy for Gram Negative Septic Shock Critical Care Canada Forum November 8, 2018 Michael Klompas MD, MPH, FIDSA, FSHEA Professor, Harvard Medical School Hospital Epidemiologist, Brigham

More information

Appropriate antimicrobial therapy in HAP: What does this mean?

Appropriate antimicrobial therapy in HAP: What does this mean? Appropriate antimicrobial therapy in HAP: What does this mean? Jaehee Lee, M.D. Kyungpook National University Hospital, Korea KNUH since 1907 Presentation outline Empiric antimicrobial choice: right spectrum,

More information

UCSF guideline for management of suspected hospital-acquired or ventilatoracquired pneumonia in adult patients

UCSF guideline for management of suspected hospital-acquired or ventilatoracquired pneumonia in adult patients Background/methods: UCSF guideline for management of suspected hospital-acquired or ventilatoracquired pneumonia in adult patients This guideline establishes evidence-based consensus standards for management

More information

Pinni Meedha Mojutho Ammanu Dengina Koduku Part 1 Kama Kathalu

Pinni Meedha Mojutho Ammanu Dengina Koduku Part 1 Kama Kathalu Search for: Search Search Does levaquin cover anaerobes Pinni Meedha Mojutho Ammanu Dengina Koduku Part 1 Kama Kathalu Levofloxacin, sold under the trade names Levaquin among others, is an antibiotic.

More information

ANTIBIOTIC STEWARDSHIP IN LONG TERM CARE

ANTIBIOTIC STEWARDSHIP IN LONG TERM CARE ANTIBIOTIC STEWARDSHIP IN LONG TERM CARE How consultant pharmacists can help their facilities by Kelli Musick-Hocker, Pharm D. Complete Pharmacy Consulting Kansas City Why is antibiotic stewardship in

More information

Antimicrobial Stewardship in Ambulatory Care

Antimicrobial Stewardship in Ambulatory Care Antimicrobial Stewardship in Ambulatory Care Nila Suntharam, M.D. May 5, 2017 Dr. Suntharam indicated no potential conflict of interest to this presentation. She does not intend to discuss any unapproved/investigative

More information

Evaluating the Role of MRSA Nasal Swabs

Evaluating the Role of MRSA Nasal Swabs Evaluating the Role of MRSA Nasal Swabs Josh Arnold, PharmD PGY1 Pharmacy Resident Pharmacy Grand Rounds February 28, 2017 2016 MFMER slide-1 Objectives Identify the pathophysiology of MRSA nasal colonization

More information

Appropriate Management of Common Pediatric Infections. Blaise L. Congeni M.D. Akron Children s Hospital Division of Pediatric Infectious Diseases

Appropriate Management of Common Pediatric Infections. Blaise L. Congeni M.D. Akron Children s Hospital Division of Pediatric Infectious Diseases Appropriate Management of Common Pediatric Infections Blaise L. Congeni M.D. Akron Children s Hospital Division of Pediatric Infectious Diseases It s all about the microorganism The common pathogens Viruses

More information

Treatment of septic peritonitis

Treatment of septic peritonitis Vet Times The website for the veterinary profession https://www.vettimes.co.uk Treatment of septic peritonitis Author : Andrew Linklater Categories : Companion animal, Vets Date : November 2, 2016 Septic

More information

Bai-Yi Chen MD. FCCP

Bai-Yi Chen MD. FCCP Treatment strategies for hospitalized versus nonhospitalized CAP patients: Asian perspective Bai-Yi Chen MD. FCCP Professor of Medicine Division of Infectious Disease, Infection Control Team The First

More information

Community-acquired pneumonia: Time to place a CAP on length of treatment?

Community-acquired pneumonia: Time to place a CAP on length of treatment? LOGIN TO LEARN: An Engaging and Interactive Journal Club for Pharmacists and Students Community-acquired pneumonia: Time to place a CAP on length of treatment? Jennifer Ball, PharmD Learning Objectives

More information

Measure Information Form Collected For: CMS Voluntary Only The Joint Commission - Retired

Measure Information Form Collected For: CMS Voluntary Only The Joint Commission - Retired Measure Information Form Collected For: CMS Voluntary Only The Joint Commission - Retired Last Updated: Version 4.3a Measure Set: Pneumonia (PN) Set Measure I #: Performance Measure Name: lood Cultures

More information

SECTION 3A. Section 3A Criteria for Optional Special Authorization of Select Drug Products

SECTION 3A. Section 3A Criteria for Optional Special Authorization of Select Drug Products SECTION 3A Criteria for Optional Special Authorization of Select Drug Products Section 3A Criteria for Optional Special Authorization of Select Drug Products CRITERIA FOR OPTIONAL SPECIAL AUTHORIZATION

More information

Management of Hospital-acquired Pneumonia

Management of Hospital-acquired Pneumonia Management of Hospital-acquired Pneumonia Adel Alothman, MB, FRCPC, FACP Asst. Professor, COM, KSAU-HS Head, Infectious Diseases, Department of Medicine King Abdulaziz Medical City Riyadh Saudi Arabia

More information

ANTIBIOTIC USE GUIDELINES FOR URINARY TRACT AND RESPIRATORY DISEASE

ANTIBIOTIC USE GUIDELINES FOR URINARY TRACT AND RESPIRATORY DISEASE ANTIBIOTIC USE GUIDELINES FOR URINARY TRACT AND RESPIRATORY DISEASE Jane Sykes, BVSc(Hons), PhD, DACVIM (SAIM) School of Veterinary Medicine Dept. of Medicine & Epidemiology University of California Davis,

More information

InPHARMation. Pharmacy and Therapeutics Committee Update May 23 rd, 2018 Meeting

InPHARMation. Pharmacy and Therapeutics Committee Update May 23 rd, 2018 Meeting VOLUME FOUR; ISSUE 5 May 23, 2018 Edited by: Gregory K. Perry, PharmD, BCPS-AQID InPHARMation Pharmacy and Therapeutics Committee Update May 23 rd, 2018 Meeting The Pharmacy and Therapeutics Committee

More information

IMPLEMENTATION AND ASSESSMENT OF A GUIDELINE-BASED TREATMENT ALGORITHM FOR COMMUNITY-ACQUIRED PNEUMONIA (CAP)

IMPLEMENTATION AND ASSESSMENT OF A GUIDELINE-BASED TREATMENT ALGORITHM FOR COMMUNITY-ACQUIRED PNEUMONIA (CAP) IMPLEMENTATION AND ASSESSMENT OF A GUIDELINE-BASED TREATMENT ALGORITHM FOR COMMUNITY-ACQUIRED PNEUMONIA (CAP) Lucas Schonsberg, PharmD PGY-1 Pharmacy Practice Resident Providence St. Patrick Hospital Missoula,

More information

Pneumonia Antibiotic Guidance for Adults PAGL Inclusion Approved at January 2017 PGC

Pneumonia Antibiotic Guidance for Adults PAGL Inclusion Approved at January 2017 PGC Pneumonia Antibiotic Guidance for Adults PAGL Inclusion Approved at January 2017 PGC APPROVED BY: Policy and Guidelines Committee TRUST REFERENCE: B9/2009 AWP Ref: AWP61 Date (approved): July 2008 REVIEW

More information

Principles of Infectious Disease. Dr. Ezra Levy CSUHS PA Program

Principles of Infectious Disease. Dr. Ezra Levy CSUHS PA Program Principles of Infectious Disease Dr. Ezra Levy CSUHS PA Program I. Microbiology (1) morphology (e.g., cocci, bacilli) (2) growth characteristics (e.g., aerobic vs anaerobic) (3) other qualities (e.g.,

More information

SHC Clinical Pathway: HAP/VAP Flowchart

SHC Clinical Pathway: HAP/VAP Flowchart SHC Clinical Pathway: Hospital-Acquired and Ventilator-Associated Pneumonia SHC Clinical Pathway: HAP/VAP Flowchart v.08-29-2017 Diagnosis Hospitalization (HAP) Pneumonia develops 48 hours following: Endotracheal

More information

Survey of Wisconsin Primary Care Clinicians

Survey of Wisconsin Primary Care Clinicians ... for our health Clinical Approach to Nonresponsive Pneumonia: A Survey of Wisconsin Primary Care Clinicians Hannah A. Louks, 1,3 Jared M. Fixmer, MD 2, and Dennis J. Baumgardner, MD 1,2,3 1 Wisconsin

More information

CME/CE QUIZ CME/CE QUESTIONS. a) 20% b) 22% c) 34% d) 35% b) Susceptible and resistant strains of typical respiratory

CME/CE QUIZ CME/CE QUESTIONS. a) 20% b) 22% c) 34% d) 35% b) Susceptible and resistant strains of typical respiratory CME/CE QUIZ CME/CE QUESTIONS Continuing Medical Education Accreditation This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for

More information

An Approach to Appropriate Antibiotic Prescribing in Outpatient and LTC Settings?

An Approach to Appropriate Antibiotic Prescribing in Outpatient and LTC Settings? An Approach to Appropriate Antibiotic Prescribing in Outpatient and LTC Settings? Dr. Andrew Morris Antimicrobial Stewardship ProgramMt. Sinai Hospital University Health Network amorris@mtsinai.on.ca andrew.morris@uhn.ca

More information

Antibiotic. Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting

Antibiotic. Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting Antibiotic Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting Any substance of natural, synthetic or semisynthetic origin which at low concentrations kills or inhibits the growth of bacteria

More information

Anaerobic antibiotic usage for pneumonia in the medical intensive care unit

Anaerobic antibiotic usage for pneumonia in the medical intensive care unit ORIGINAL ARTICLE Anaerobic antibiotic usage for pneumonia in the medical intensive care unit MUTSUMI J. KIOKA, BRUNO DIGIOVINE, MOHAMED REZIK AND JEFFREY H. JENNINGS Division of Pulmonary and Critical

More information

General Approach to Infectious Diseases

General Approach to Infectious Diseases General Approach to Infectious Diseases 2 The pharmacotherapy of infectious diseases is unique. To treat most diseases with drugs, we give drugs that have some desired pharmacologic action at some receptor

More information

Approach to pediatric Antibiotics

Approach to pediatric Antibiotics Approach to pediatric Antibiotics Gassem Gohal FAAP FRCPC Assistant professor of Pediatrics objectives To be familiar with common pediatric antibiotics o Classification o Action o Adverse effect To discus

More information

Host. Case Discussion: optimizing Antimicrobial therapy in Real Practice. To optimize antimicrobial use

Host. Case Discussion: optimizing Antimicrobial therapy in Real Practice. To optimize antimicrobial use Case Discussion: optimizing Antimicrobial therapy in Real Practice Sang Usayaporn, B.Pharm Prof. Terapong Tantawichien, M.D. Chulalongkorn University Griffith M, Postelnick M, Scheetz M. Expert Rev Anti

More information

10/13/14. Low: not well absorbed. Good: [blood and tissue] < than if given IV. High: > 90% absorption orally

10/13/14. Low: not well absorbed. Good: [blood and tissue] < than if given IV. High: > 90% absorption orally Low: not well absorbed PO agent not for serious infection nitrofurantoin Good: [blood and tissue] < than if given IV [Therapeutic] in excess of [effective] eg. cephalexin High: > 90% absorption orally

More information

Aberdeen Hospital. Antibiotic Susceptibility Patterns For Commonly Isolated Organisms For 2015

Aberdeen Hospital. Antibiotic Susceptibility Patterns For Commonly Isolated Organisms For 2015 Aberdeen Hospital Antibiotic Susceptibility Patterns For Commonly Isolated s For 2015 Services Laboratory Microbiology Department Aberdeen Hospital Nova Scotia Health Authority 835 East River Road New

More information

Antibiotic Abyss. Discussion Points. MRSA Treatment Guidelines

Antibiotic Abyss. Discussion Points. MRSA Treatment Guidelines Antibiotic Abyss Fredrick M. Abrahamian, D.O., FACEP, FIDSA Professor of Medicine UCLA School of Medicine Director of Education Department of Emergency Medicine Olive View-UCLA Medical Center Sylmar, California

More information

Antibiotic usage in nosocomial infections in hospitals. Dr. Birgit Ross Hospital Hygiene University Hospital Essen

Antibiotic usage in nosocomial infections in hospitals. Dr. Birgit Ross Hospital Hygiene University Hospital Essen Antibiotic usage in nosocomial infections in hospitals Dr. Birgit Ross Hospital Hygiene University Hospital Essen Infection control in healthcare settings - Isolation - Hand Hygiene - Environmental Hygiene

More information

AZITHROMYCIN, DOXYCYCLINE, AND FLUOROQUINOLONES

AZITHROMYCIN, DOXYCYCLINE, AND FLUOROQUINOLONES AZITHROMYCIN, DOXYCYCLINE, AND FLUOROQUINOLONES Update in Medicine and Primary Care Whitney R. Buckel, PharmD, BCPS-AQ ID System Antimicrobial Stewardship Pharmacist Manager OBJECTIVES 1. List three antibiotics

More information

ORIGINAL INVESTIGATION. Causes and Factors Associated With Early Failure in Hospitalized Patients With Community-Acquired Pneumonia

ORIGINAL INVESTIGATION. Causes and Factors Associated With Early Failure in Hospitalized Patients With Community-Acquired Pneumonia ORIGINAL INVESTIGATION Causes and Factors Associated With Failure in Hospitalized Patients With Community-Acquired Pneumonia Beatriz Rosón, MD; Jordi Carratalà, MD; Núria Fernández-Sabé, MD; Fe Tubau,

More information

Pneumonia. Community Acquired Pneumonia (CAP): definition. At least 2 new symptoms

Pneumonia. Community Acquired Pneumonia (CAP): definition. At least 2 new symptoms Pneumonia Lisa G. Winston, MD University of California, San Francisco San Francisco General Hospital Community Acquired Pneumonia (CAP): definition At least 2 new symptoms Fever or hypothermia Cough Rigors

More information

Central Nervous System Infections

Central Nervous System Infections Central Nervous System Infections Meningitis Treatment Bacterial meningitis is a MEDICAL EMERGENCY. ANTIBIOTICS SHOULD BE STARTED AS SOON AS THE POSSIBILITY OF BACTERIAL MENINGITIS BECOMES EVIDENT, IDEALLY

More information

Antibiotic Stewardship in the LTC Setting

Antibiotic Stewardship in the LTC Setting Antibiotic Stewardship in the LTC Setting Joe Litsey, Director of Consulting Services Pharm.D., Board Certified Geriatric Pharmacist Thrifty White Pharmacy Objectives Describe the Antibiotic Stewardship

More information

National Clinical Guideline Centre Pneumonia Diagnosis and management of community- and hospital-acquired pneumonia in adults

National Clinical Guideline Centre Pneumonia Diagnosis and management of community- and hospital-acquired pneumonia in adults National Clinical Guideline Centre Antibiotic classifications Pneumonia Diagnosis and management of community- and hospital-acquired pneumonia in adults Clinical guideline 191 Appendix N 3 December 2014

More information

ORIGINAL INVESTIGATION. Doxycycline Is a Cost-effective Therapy for Hospitalized Patients With Community-Acquired Pneumonia

ORIGINAL INVESTIGATION. Doxycycline Is a Cost-effective Therapy for Hospitalized Patients With Community-Acquired Pneumonia ORIGINAL INVESTIGATION Doxycycline Is a Cost-effective Therapy for Hospitalized Patients With Community-Acquired Pneumonia Reba K. Ailani, MD; Gautami Agastya, MD; Rajesh K. Ailani, MD; Beejadi N. Mukunda,

More information

Let me clear my throat: empiric antibiotics in

Let me clear my throat: empiric antibiotics in Let me clear my throat: empiric antibiotics in respiratory tract infections Alexander John Langley, MD MS MPH Goals of this talk Overuse of antibiotics is a major issue, as a result many specialist medical

More information

Methicillin-Resistant Staphylococcus aureus Nasal Swabs as a Tool in Antimicrobial Stewardship

Methicillin-Resistant Staphylococcus aureus Nasal Swabs as a Tool in Antimicrobial Stewardship Methicillin-Resistant Staphylococcus aureus Nasal Swabs as a Tool in Antimicrobial Stewardship Natalie R. Tucker, PharmD Antimicrobial Stewardship Pharmacist Tyson E. Dietrich, PharmD PGY2 Infectious Diseases

More information

Community-Acquired Pneumonia. Community-Acquired Pneumonia. Community Acquired Pneumonia (CAP): definition

Community-Acquired Pneumonia. Community-Acquired Pneumonia. Community Acquired Pneumonia (CAP): definition Community-Acquired Pneumonia Lisa G. Winston, MD University of California, San Francisco San Francisco General Hospital Community-Acquired Pneumonia Talk will focus on adults Guideline for healthy infants

More information

ACUTE EXACERBATIONS of COPD (AE-COPD) : The Belgian perspective

ACUTE EXACERBATIONS of COPD (AE-COPD) : The Belgian perspective ACUTE EXACERBATIONS of COPD (AE-COPD) : The Belgian perspective Antwerpen 8 november 2002 Yvan Valcke MD PhD AZ Maria Middelares Sint-Niklaas ACUTE EXACERBATIONS of COPD (AE-COPD) Treatment of AECB Role

More information

THERAPY OF ANAEROBIC INFECTIONS LUNG ABSCESS BRAIN ABSCESS

THERAPY OF ANAEROBIC INFECTIONS LUNG ABSCESS BRAIN ABSCESS THERAPY OF ANAEROBIC INFECTIONS Douglas Black, Pharm.D. Associate Professor School of Pharmacy University of Washington dblack@u.washington.edu LUNG ABSCESS A lung abscess is a localized pus cavity in

More information

MAGNITUDE OF ANTIMICROBIAL USE. Antimicrobial Stewardship in Acute and Long Term Healthcare Facilities: Design, Implementation and Challenges

MAGNITUDE OF ANTIMICROBIAL USE. Antimicrobial Stewardship in Acute and Long Term Healthcare Facilities: Design, Implementation and Challenges Antimicrobial Stewardship in Acute and Long Term Healthcare Facilities: Design, Implementation and Challenges John A. Jernigan, MD, MS Division of Healthcare Quality Promotion Centers for Disease Control

More information

Childrens Hospital Antibiogram for 2012 (Based on data from 2011)

Childrens Hospital Antibiogram for 2012 (Based on data from 2011) Childrens Hospital Antibiogram for 2012 (Based on data from 2011) Prepared by: Department of Clinical Microbiology, Health Sciences Centre For further information contact: Andrew Walkty, MD, FRCPC Medical

More information

CLINICAL USE OF BETA-LACTAMS

CLINICAL USE OF BETA-LACTAMS CLINICAL USE OF BETA-LACTAMS Douglas Black, Pharm.D. Associate Professor School of Pharmacy University of Washington dblack@u.washington.edu WHY IS INFECTIOUS DISEASE PHARMACOTHERAPY SO CONFUSING? Microbial

More information

Levofloxacin and moxifloxacin resistant Haemophilus influenzae in a patient with common variable immunodeficiency (CVID): a case report

Levofloxacin and moxifloxacin resistant Haemophilus influenzae in a patient with common variable immunodeficiency (CVID): a case report 46 Case Report Levofloxacin and moxifloxacin resistant Haemophilus influenzae in a patient with common variable immunodeficiency (CVID): a case report CT Hapuarachchi 1, GK Karunaratne 2, NR de Silva 3,

More information

Infectious Disease 101: Helping the Consultant Pharmacist with Stewardship Principles

Infectious Disease 101: Helping the Consultant Pharmacist with Stewardship Principles Infectious Disease 101: Helping the Consultant Pharmacist with Stewardship Principles Conflicts of Interest None at this time May be discussing off-label indications KALIN M. CLIFFORD, PHARM.D., BCPS,

More information

4/3/2017 CLINICAL PEARLS: UPDATES IN THE MANAGEMENT OF NOSOCOMIAL PNEUMONIA DISCLOSURE LEARNING OBJECTIVES

4/3/2017 CLINICAL PEARLS: UPDATES IN THE MANAGEMENT OF NOSOCOMIAL PNEUMONIA DISCLOSURE LEARNING OBJECTIVES CLINICAL PEARLS: UPDATES IN THE MANAGEMENT OF NOSOCOMIAL PNEUMONIA BILLIE BARTEL, PHARMD, BCCCP APRIL 7 TH, 2017 DISCLOSURE I have had no financial relationship over the past 12 months with any commercial

More information

Outpatient Antimicrobial Therapy. Role of Antibacterials in Outpatient Treatment of Respiratory Tract Infection. Acute Bacterial Rhinosinusitis

Outpatient Antimicrobial Therapy. Role of Antibacterials in Outpatient Treatment of Respiratory Tract Infection. Acute Bacterial Rhinosinusitis Outpatient Antimicrobial Therapy B. Joseph Guglielmo, Pharm.D. Professor and Chair Department of Clinical Pharmacy University of California San Francisco Role of Antibacterials in Outpatient Treatment

More information

The Three R s Rethink..Reduce..Rocephin

The Three R s Rethink..Reduce..Rocephin The Three R s Rethink..Reduce..Rocephin By: Alisa Cuff RN,BN,CIC and John Bautista B.Sc. (Chem), B.Sc.Pharm, M.Sc.Pharm IPAC National Conference 2017 Newfoundland and Labrador Regional Health Authorities

More information

EVIDENCE BASED MEDICINE: ANTIBIOTIC RESISTANCE IN THE ELDERLY CHETHANA KAMATH GERIATRIC MEDICINE WEEK

EVIDENCE BASED MEDICINE: ANTIBIOTIC RESISTANCE IN THE ELDERLY CHETHANA KAMATH GERIATRIC MEDICINE WEEK EVIDENCE BASED MEDICINE: ANTIBIOTIC RESISTANCE IN THE ELDERLY CHETHANA KAMATH GERIATRIC MEDICINE WEEK EPIDEMIOLOGY AND BACKGROUND Every year, more than 2 million people in the United States acquire antibiotic-resistant

More information

The International Collaborative Conference in Clinical Microbiology & Infectious Diseases

The International Collaborative Conference in Clinical Microbiology & Infectious Diseases The International Collaborative Conference in Clinical Microbiology & Infectious Diseases PLUS: Antimicrobial stewardship in hospitals: Improving outcomes through better education and implementation of

More information

Rational use of antibiotic in upper respiratory tract infection (URI) and community acquired pneumonia รศ.จามร ธ รตก ลพ ศาล 23 พฤษภาคม 2550

Rational use of antibiotic in upper respiratory tract infection (URI) and community acquired pneumonia รศ.จามร ธ รตก ลพ ศาล 23 พฤษภาคม 2550 Rational use of antibiotic in upper respiratory tract infection (URI) and community acquired pneumonia รศ.จามร ธ รตก ลพ ศาล 23 พฤษภาคม 2550 Sinusitis Upper respiratory tract infections (URI) Common cold

More information

Pneumococcal urinary antigen test use in diagnosis and treatment of pneumonia in seven Utah hospitals

Pneumococcal urinary antigen test use in diagnosis and treatment of pneumonia in seven Utah hospitals ORIGINAL ARTICLE PNEUMONIA Pneumococcal urinary antigen test use in diagnosis and treatment of pneumonia in seven Utah hospitals Devin M. West 1, Lindsay M. McCauley 2,3, Jeffrey S. Sorensen 2, Al R. Jephson

More information

Community-Acquired Pneumonia Current & Future State

Community-Acquired Pneumonia Current & Future State Community-Acquired Pneumonia Current & Future State Brad Sharpe, M.D. Professor of Clinical Medicine Department of Medicine UCSF sharpeb@medicine.ucsf.edu I have no relevant financial relationships to

More information

Give the Right Antibiotics in Trauma Mitchell J Daley, PharmD, BCPS

Give the Right Antibiotics in Trauma Mitchell J Daley, PharmD, BCPS Give the Right Antibiotics in Trauma Mitchell J Daley, PharmD, BCPS Clinical Pharmacy Specialist, Critical Care Dell Seton Medical Center at the University of Texas and Seton Healthcare Family Clinical

More information

Marc Decramer 3. Respiratory Division, University Hospitals Leuven, Leuven, Belgium

Marc Decramer 3. Respiratory Division, University Hospitals Leuven, Leuven, Belgium AAC Accepts, published online ahead of print on April 0 Antimicrob. Agents Chemother. doi:./aac.0001- Copyright 0, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

More information

Active Bacterial Core Surveillance Site and Epidemiologic Classification, United States, 2005a. Copyright restrictions may apply.

Active Bacterial Core Surveillance Site and Epidemiologic Classification, United States, 2005a. Copyright restrictions may apply. Impact of routine surgical ward and intensive care unit admission surveillance cultures on hospital-wide nosocomial methicillin-resistant Staphylococcus aureus infections in a university hospital: an interrupted

More information

moxifloxacin intravenous, 400mg/250mL, solution for infusion (Avelox ) SMC No. (650/10) Bayer Schering

moxifloxacin intravenous, 400mg/250mL, solution for infusion (Avelox ) SMC No. (650/10) Bayer Schering moxifloxacin intravenous, 400mg/250mL, solution for infusion (Avelox ) SMC No. (650/10) Bayer Schering 05 November 2010 The Scottish Medicines Consortium (SMC) has completed its assessment of the above

More information

Antibiotic Therapy and 48-Hour Mortality for Patients with Pneumonia

Antibiotic Therapy and 48-Hour Mortality for Patients with Pneumonia The American Journal of Medicine (2006) 119, 859-864 CLINICAL RESEARCH STUDY AJM Theme Issue: Pulmonology/Allergy Antibiotic Therapy and 48-Hour Mortality for Patients with Pneumonia Eric M. Mortensen,

More information

9/9/2015. Disclosure / Contact. Pneumonia Stats. Exploring the Clinical and Regulatory Impact of Pneumonia in Long Term Care

9/9/2015. Disclosure / Contact. Pneumonia Stats. Exploring the Clinical and Regulatory Impact of Pneumonia in Long Term Care Exploring the Clinical and Regulatory Impact of Pneumonia in Long Term Care Rob Shulman R.Ph. CGP FASCP Director of Consulting Services Remedi SeniorCare William M. Vaughan,RN, BSN Vice President, Education

More information

Role of the nurse in diagnosing infection: The right sample, every time

Role of the nurse in diagnosing infection: The right sample, every time BROUGHT TO YOU BY Role of the nurse in diagnosing infection: The right sample, every time The module has been written by Shanika Anne-Marie Crusz and Amelia Joseph Authors affiliation: Department of Clinical

More information

Management of Native Valve

Management of Native Valve Management of Native Valve Infective Endocarditis 2005 AHA 2015 Baddour LM, et al. Circulation. 2015;132(15):1435-86 2009 ESC 2015 Habib G, et al. Eur Heart J. 2015;36(44):3075-128 ESC 2015: Endocarditis

More information

Antibacterial Resistance: Research Efforts. Henry F. Chambers, MD Professor of Medicine University of California San Francisco

Antibacterial Resistance: Research Efforts. Henry F. Chambers, MD Professor of Medicine University of California San Francisco Antibacterial Resistance: Research Efforts Henry F. Chambers, MD Professor of Medicine University of California San Francisco Resistance Resistance Dose-Response Curve Antibiotic Exposure Anti-Resistance

More information

Optimizing Antimicrobial Stewardship Activities Based on Institutional Resources

Optimizing Antimicrobial Stewardship Activities Based on Institutional Resources Optimizing Antimicrobial Stewardship Activities Based on Institutional Resources Andrew Hunter, PharmD, BCPS Infectious Diseases Clinical Pharmacy Specialist Michael E. DeBakey VA Medical Center Andrew.hunter@va.gov

More information

Duke University Hospital Guideline for Empiric Inpatient Treatment of Cancer- Related Neutropenic Fever in Adult Patients

Duke University Hospital Guideline for Empiric Inpatient Treatment of Cancer- Related Neutropenic Fever in Adult Patients Duke University Hospital Guideline for Empiric Inpatient Treatment of Cancer- Related Neutropenic Fever in Adult Patients PURPOSE Fever among neutropenic patients is common and a significant cause of morbidity

More information

Concise Antibiogram Toolkit Background

Concise Antibiogram Toolkit Background Background This toolkit is designed to guide nursing homes in creating their own antibiograms, an important tool for guiding empiric antimicrobial therapy. Information about antibiograms and instructions

More information

VCH PHC SURGICAL PROPHYLAXIS RECOMMENDATIONS

VCH PHC SURGICAL PROPHYLAXIS RECOMMENDATIONS VCH PHC SURGICAL PROPHYLAXIS RECOMMENDATIONS CARDIAC Staphylococcus aureus, S. epidermidis, except for For patients with known MRSA colonization, recommend decolonization with Antimicrobial Photodynamic

More information

OPTIMIZATION OF PK/PD OF ANTIBIOTICS FOR RESISTANT GRAM-NEGATIVE ORGANISMS

OPTIMIZATION OF PK/PD OF ANTIBIOTICS FOR RESISTANT GRAM-NEGATIVE ORGANISMS HTIDE CONFERENCE 2018 OPTIMIZATION OF PK/PD OF ANTIBIOTICS FOR RESISTANT GRAM-NEGATIVE ORGANISMS FEDERICO PEA INSTITUTE OF CLINICAL PHARMACOLOGY DEPARTMENT OF MEDICINE, UNIVERSITY OF UDINE, ITALY SANTA

More information

Antibiotic Stewardship in Nursing Homes SAM GUREVITZ PHARM D, CGP ASSOCIATE PROFESSOR BUTLER UNIVERSITY COLLEGE OF PHARMACY AND HEALTH SCIENCE

Antibiotic Stewardship in Nursing Homes SAM GUREVITZ PHARM D, CGP ASSOCIATE PROFESSOR BUTLER UNIVERSITY COLLEGE OF PHARMACY AND HEALTH SCIENCE Antibiotic Stewardship in Nursing Homes SAM GUREVITZ PHARM D, CGP ASSOCIATE PROFESSOR BUTLER UNIVERSITY COLLEGE OF PHARMACY AND HEALTH SCIENCE Crisis: Antibiotic Resistance Success Strategy WWW.optimistic-care.org

More information

Antimicrobial treatment of community acquired pneumonia in adults: A conference report

Antimicrobial treatment of community acquired pneumonia in adults: A conference report CONSENSUS CONFERENCE Antimicrobial treatment of community acquired pneumonia in adults: A conference report THE CANADIAN COMMUNITY ACQUIRED PNEUMONIA CONSENSUS CONFERENCE GROUP C OMMUNLTY ACQUIRED PNEUMONI

More information

Antimicrobial Stewardship Strategy: Antibiograms

Antimicrobial Stewardship Strategy: Antibiograms Antimicrobial Stewardship Strategy: Antibiograms A summary of the cumulative susceptibility of bacterial isolates to formulary antibiotics in a given institution or region. Its main functions are to guide

More information

Vaccination as a potential strategy to combat Antimicrobial Resistance in the elderly

Vaccination as a potential strategy to combat Antimicrobial Resistance in the elderly Vaccination as a potential strategy to combat Antimicrobial Resistance in the elderly Wilbur Chen, MD, MS 22-23 March 2017 WHO meeting on Immunization of the Elderly The Problem Increasing consumption

More information